Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Strand Life Sciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10800
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequencing, high throughput microscopy and digital PCR. It offers clinical research and development services to pharmaceutical and biotechnology companies in the areas of clinical trial management, biomarker discovery, and validation. Strand Life’s software platform provides analysis, management and visualization tools for next-generation sequencing data. The company offers advisory services on genetics of cancer and inherited diseases. It operates in Bangalore, Ahmedabad, New Delhi, Gulbarga, Jaipur, Hosur, Hubli, Mumbai, Nagpur, Noida, Ghaziabad, Vizag and Cuttack. Strand Life is headquartered in Bangalore, Karnataka, India.

Strand Life Sciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Strand Life Sciences Pvt Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Strand Life Sciences Raises US$10 Million In Series B Financing 11
Private Equity 12
Strand Life Sciences Raises up to USD12.4 Million in Private Equity Financing 12
Partnerships 13
ReadSense Genomic Center Enters into Co-Development Agreement with Strand Life Sciences 13
Tataa Biocenter Enters into Distribution Agreement with Strand Life Sciences 14
Strand Life Sciences to Form Joint Venture with MRIGlobal 15
Triesta Sciences To Form Joint Venture With Strand Life Sciences 16
Equity Offering 17
Strand Life Sciences Plans to Raise Funds Through IPO of Shares 17
Strand Life Sciences Pvt Ltd – Key Competitors 18
Strand Life Sciences Pvt Ltd – Key Employees 19
Strand Life Sciences Pvt Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Mar 13, 2018: High Prevalence of Hereditary Breast and/or Ovarian Cancer Among Patients in India 21
Jul 14, 2017: Cancer-causing BRCA Gene Mutations at Least Three Times More Prevalent in India Compared to Western Countries Reveals Study 22
Product News 23
Oct 17, 2017: Strand Life Sciences Announces the Release of Strand NGS v3.1 at ASHG 2017 23
Other Significant Developments 24
Sep 27, 2017: Strand Life Sciences to showcase Strand NGS, analysis software for next-generation sequencing data at ASHG 2017 24
Apr 03, 2017: Strand Life Sciences Creates Another Global Bioinformatics Landmark With Strand Ramanujan 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strand Life Sciences Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Strand Life Sciences Pvt Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Strand Life Sciences Raises US$10 Million In Series B Financing 11
Strand Life Sciences Raises up to USD12.4 Million in Private Equity Financing 12
ReadSense Genomic Center Enters into Co-Development Agreement with Strand Life Sciences 13
Tataa Biocenter Enters into Distribution Agreement with Strand Life Sciences 14
Strand Life Sciences to Form Joint Venture with MRIGlobal 15
Triesta Sciences To Form Joint Venture With Strand Life Sciences 16
Strand Life Sciences Plans to Raise Funds Through IPO of Shares 17
Strand Life Sciences Pvt Ltd, Key Competitors 18
Strand Life Sciences Pvt Ltd, Key Employees 19

List of Figures
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Strand Life Sciences Pvt Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neuland Laboratories Ltd (NEULANDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeuti …
  • Rebiotix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that develops treatments for debilitating diseases. The company targets various disease conditions using drugs based on its microbiota restoration therapy platform. It lead product candidate RBX2660 is u …
  • Rose Petroleum plc (ROSE):石油・ガス:M&Aディール及び事業提携情報
    Summary Rose Petroleum plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • Hemispherx Biopharma Inc (HEB):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Presbia Plc (LENS):医療機器:M&Aディール及び事業提携情報
    Summary Presbia Plc (Presbia) is a medical device company. The company develops presbyopia-correcting presbia flexivue microlens, a solutions for the age-related loss of the ability to read or focus on near objects. Its microlens helps people to read newspapers, restaurant menus, cell phone messages …
  • Nanovis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company offers products such as implant nanosurfaces, implantable scaffolds and cervical plate, lumbar PEEK interbody systems, pedicle screws, injectable bi …
  • Harvard Medical School:企業のM&A・事業提携・投資動向
    Harvard Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harvard Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Red Electrica Corporacion SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red El …
  • Electrabel SA:企業の戦略的SWOT分析
    Electrabel SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ulthera Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ulthera Inc (Ulthera), a subsidiary of Merz Pharma GmbH & Co KgaA is a medical device company that develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technologies. The company’s therapeutic ultrasound platform technolo …
  • Hudson Pacific Properties Inc:企業のM&A・事業提携・投資動向
    Hudson Pacific Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hudson Pacific Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Burger-In Oy:戦略・SWOT・企業財務分析
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • HumanOptics AG (H9O1):企業の財務・戦略的SWOT分析
    Summary HumanOptics AG (HumanOptics), a subsidiary of Medipart AG, is a medical device company that develops, manufactures and distributes intraocular implants for opthalmic surgeries. The company offers products such as intraocular lenses, artificiallris, capsular tension rings and cornea implants. …
  • China Southern Airlines Company Limited:企業の戦略・SWOT・財務情報
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Pliant Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pliant Therapeutics Inc (Pliant Therapeutics) is a biotechnology company that strives to discover, develop and commercialize treatments for fibrotic diseases. The company harnesses its capabilities in integrin biology, medicinal chemistry, clinical insight and TGF-ß modulation to block or re …
  • Hammerson plc:企業のM&A・事業提携・投資動向
    Hammerson plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hammerson plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Hansol Logistics Co., Ltd. (009180):企業の財務・戦略的SWOT分析
    Hansol Logistics Co., Ltd. (009180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Premaitha Health Plc (NIPT):医療機器:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Williams-Sonoma, Inc.:企業の戦略・SWOT・財務情報
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Suncorp Group Ltd:企業のM&A・事業提携・投資動向
    Suncorp Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Suncorp Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆